Long-Term Naturalistic Follow-Up of Patients With Bipolar Depression and Mixed State Treated With Electroconvulsive Therapy

2013 ◽  
Vol 29 (3) ◽  
pp. 179-188 ◽  
Author(s):  
Pierpaolo Medda ◽  
Mauro Mauri ◽  
Sara Fratta ◽  
Benedetta Ciaponi ◽  
Mario Miniati ◽  
...  
2020 ◽  
Vol 32 (S1) ◽  
pp. 91-91

AUTHORS:Kerstin Johansson, Karolina Thömkvist, Ingmar Skoog and Sacuiu SF* (*presenter)OBJECTIVE:To determine the effects of electroconvulsive therapy (ECT) in major depression in relation to the development of dementia during long-term follow-up.METHOD:In an observational clinical prospective study of consecutive patients 70 years and older diagnosed with major depression at baseline 2000-2004 (n=1090), who were free of dementia and received antidepressant treatment, with or without ECT, we sought to determine if cognitive decline (mild cognitive impairment and dementia) during 15 -year follow-up was associated with receiving ECT at baseline. The control group was selected among the participants in the Gothenburg H70 Birth Cohort Studies matched by age group and sex 1:1.RESULTS:Among patients with affective syndromes 7% received ECT. During follow-up, 157 patients were diagnosed with dementia, equal proportions among those who received ECT (14.5%) and those who did not receive ECT (14.5%). The relation between ECT and cognitive decline remained non-significant irrespective antidepressive medication or presence of mild cognitive impairment at baseline.CONCLUSION:Preliminary results indicate that ECT was not associated with the development of cognitive decline in the long-term in a hospital-based cohort of 70+ year-olds. The results remain to verify against controls from a representative community sample.


2019 ◽  
Vol 29 ◽  
pp. S228
Author(s):  
I. Laria Bustillo ◽  
N. Olazabal ◽  
S. Bustamante ◽  
M.A. Madrazo ◽  
L. Osa ◽  
...  

2015 ◽  
Vol 184 ◽  
pp. 137-144 ◽  
Author(s):  
Esmée Verwijk ◽  
Harm-Pieter Spaans ◽  
Hannie C. Comijs ◽  
King H. Kho ◽  
Pascal Sienaert ◽  
...  

2017 ◽  
Vol 15 (3) ◽  
pp. 359-371 ◽  
Author(s):  
Giulio Perugi ◽  
Pierpaolo Medda ◽  
Cristina Toni ◽  
Michela Mariani ◽  
Chiara Socci ◽  
...  

2011 ◽  
Vol 23 (3) ◽  
pp. 94-105 ◽  
Author(s):  
Antonio Tundo ◽  
Paola Cavalieri ◽  
Serena Navari ◽  
Fulvia Marchetti

Objective: Although depressive symptoms are preponderant in the course of bipolar (BP) disorders, the treatment of BP depression remains a controversial issue with different clinical approaches available. This review addresses the issues of whether antidepressants (ADs) are effective in treating acute and long-term BP depression, risks linked to ADs and what alternatives to ADs are available.Methods: We searched the MEDLINE databases using the following syntax: [bipolar depression AND unipolar depression AND (antidepressants OR anticonvulsants OR lithium OR antipsychotics OR dopamine-agonists OR psychoeducation OR psychotherapy OR electroconvulsive therapy OR transcranial magnetic stimulation)]. The search included studies published up to 31 May 2009 and conducted on adults.Results: In the acute treatment of BP depression ADs are effective with no differences among drug classes. However, neither the switch into (hypo)mania induction rate nor the suicide risk linked to AD use are definitely established. The effectiveness of long-term AD use is limited to highly selected samples of patients with positive acute response. The risk of long-term ADs causing cycle acceleration and rapid cycling induction concerns a subpopulation of patients. Valid alternatives to ADs in treating acute BP depression are quetiapine, an olanzapine–fluoxetine combination, and electroconvulsive therapy for more severe patients. Lamotrigine is effective and safe in preventing depressive relapses. Psychotherapy and psychoeducation represent effective adjunctive treatments.Conclusion: In the treatment of BP depression there is not a specific effective treatment for all the patients. Interventions should therefore be personalised and the scientific evidence should be adapted to each patient's clinical features.


2021 ◽  
Vol 53 ◽  
pp. S278
Author(s):  
S. Lambrichts ◽  
M.J. Wagenmakers ◽  
K. Vansteelandt ◽  
J. Obbels ◽  
S. Schouws ◽  
...  

2005 ◽  
Vol 21 (4) ◽  
pp. 214-220 ◽  
Author(s):  
Aki Johanson ◽  
Lars Gustafson ◽  
Jarl Risberg ◽  
Ingmar Ros??n ◽  
Martin Sj??beck ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document